BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 27907841)

  • 1. Bacterial E3 ligase effectors exploit host ubiquitin systems.
    Ashida H; Sasakawa C
    Curr Opin Microbiol; 2017 Feb; 35():16-22. PubMed ID: 27907841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revisiting Bacterial Ubiquitin Ligase Effectors: Weapons for Host Exploitation.
    Pisano A; Albano F; Vecchio E; Renna M; Scala G; Quinto I; Fiume G
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30428531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytosol as battleground: ubiquitin as a weapon for both host and pathogen.
    Collins CA; Brown EJ
    Trends Cell Biol; 2010 Apr; 20(4):205-13. PubMed ID: 20129784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification of the host ubiquitome by bacterial enzymes.
    Berglund J; Gjondrekaj R; Verney E; Maupin-Furlow JA; Edelmann MJ
    Microbiol Res; 2020 May; 235():126429. PubMed ID: 32109687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of Host-Pathogen Interactions via the Ubiquitin System.
    Mukherjee R; Dikic I
    Annu Rev Microbiol; 2022 Sep; 76():211-233. PubMed ID: 36075095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hijacking the host ubiquitin pathway: structural strategies of bacterial E3 ubiquitin ligases.
    Hicks SW; Galán JE
    Curr Opin Microbiol; 2010 Feb; 13(1):41-6. PubMed ID: 20036613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pathogen type III effector with a novel E3 ubiquitin ligase architecture.
    Singer AU; Schulze S; Skarina T; Xu X; Cui H; Eschen-Lippold L; Egler M; Srikumar T; Raught B; Lee J; Scheel D; Savchenko A; Bonas U
    PLoS Pathog; 2013 Jan; 9(1):e1003121. PubMed ID: 23359647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sumoylation as an Integral Mechanism in Bacterial Infection and Disease Progression.
    Srikanth CV; Verma S
    Adv Exp Med Biol; 2017; 963():389-408. PubMed ID: 28197924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diversity of bacterial manipulation of the host ubiquitin pathways.
    Zhou Y; Zhu Y
    Cell Microbiol; 2015 Jan; 17(1):26-34. PubMed ID: 25339545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type III Secreted Virulence Factors Manipulating Signaling to Actin Dynamics.
    Stradal TE; Costa SC
    Curr Top Microbiol Immunol; 2017; 399():175-199. PubMed ID: 27744505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploitation of eukaryotic ubiquitin signaling pathways by effectors translocated by bacterial type III and type IV secretion systems.
    Angot A; Vergunst A; Genin S; Peeters N
    PLoS Pathog; 2007 Jan; 3(1):e3. PubMed ID: 17257058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging insights into bacterial deubiquitinases.
    Kubori T; Kitao T; Nagai H
    Curr Opin Microbiol; 2019 Feb; 47():14-19. PubMed ID: 30391778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteria-host relationship: ubiquitin ligases as weapons of invasion.
    Maculins T; Fiskin E; Bhogaraju S; Dikic I
    Cell Res; 2016 Apr; 26(4):499-510. PubMed ID: 26964724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor Necrosis Factor Receptor-Associated Factor 6 (TRAF6) Mediates Ubiquitination-Dependent STAT3 Activation upon Salmonella enterica Serovar Typhimurium Infection.
    Ruan HH; Zhang Z; Wang SY; Nickels LM; Tian L; Qiao JJ; Zhu J
    Infect Immun; 2017 Aug; 85(8):. PubMed ID: 28507064
    [No Abstract]   [Full Text] [Related]  

  • 15. The NEL Family of Bacterial E3 Ubiquitin Ligases.
    Bullones-Bolaños A; Bernal-Bayard J; Ramos-Morales F
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploitation of the host cell ubiquitin machinery by microbial effector proteins.
    Lin YH; Machner MP
    J Cell Sci; 2017 Jun; 130(12):1985-1996. PubMed ID: 28476939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SecretEPDB: a comprehensive web-based resource for secreted effector proteins of the bacterial types III, IV and VI secretion systems.
    An Y; Wang J; Li C; Revote J; Zhang Y; Naderer T; Hayashida M; Akutsu T; Webb GI; Lithgow T; Song J
    Sci Rep; 2017 Jan; 7():41031. PubMed ID: 28112271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global Analysis of Host and Bacterial Ubiquitinome in Response to Salmonella Typhimurium Infection.
    Fiskin E; Bionda T; Dikic I; Behrends C
    Mol Cell; 2016 Jun; 62(6):967-981. PubMed ID: 27211868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ubiquitin ligation machinery in the defense against bacterial pathogens.
    Tripathi-Giesgen I; Behrends C; Alpi AF
    EMBO Rep; 2021 Nov; 22(11):e52864. PubMed ID: 34515402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of host cell ubiquitination machinery by pathogenic bacteria.
    Alomairi J; Bonacci T; Ghigo E; Soubeyran P
    Front Cell Infect Microbiol; 2015; 5():17. PubMed ID: 25774357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.